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Background: Serotonin (5-hydroytryptamine or 5HT) is associated with numerous behavioral and psychological
factors and is a biochemical marker of mood. 5HT is involved in the hypothalamic regulation of energy consumption.
5HT controls appetite in the central nerve system (CNS) and stimulates intestinal mobility. There are few studies looking
at the role of 5HT and the relationship between peripheral circulating serotonin and obesity. The aim of this study was
to find any differences in leptin, adiponectin, and 5HT between lean and obese dogs and to identify correlations
among these factors.
Results: Leptin, triglyceride (TG) and cholesterol levels were higher in the obese group (all p < 0.01). Adiponectin
and 5HT levels were higher in the lean group compared to the obese group (p < 0.01). Leptin (r = 0.628, p < 0.01),
TG (r = 0.491, p < 0.01) and cholesterol (r = 0.419, p < 0.01) were positively correlated with body condition score (BCS),
and adiponectin (r = −0.446, p < 0.01) and 5HT (r = −0.490, p < 0.01) were negatively correlated with BCS. Leptin was
negatively correlated with adiponectin (r = −0.294, p < 0.01) and 5HT (r = −0.343, p < 0.01). 5HT was negatively
correlated with leptin (r = −0.343, p < 0.01), TG (r = −0.268, p < 0.05) and cholesterol (r = −0.357, p < 0.05).
Conclusions: 5HT is an important appetite control neurotransmitter, but there are limited studies for 5HT levels
related to obesity in dogs. To the best of our knowledge, this is the first study to evaluate peripheral 5HT levels in
obese dogs. From this research, we can assume that 5HT may be correlated with canine obesity. Further studies
will be needed to further elucidate the role of low serum 5HT levels in canine obesity.
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Obesity is a disease characterized by excessive adipose
tissue accumulation in the body. It is a common nutri-
tional problem in small animal medicine [1,2]. Ideally,
fat mass accounts for approximately 15% to 20% in dogs
and cats [3,4]. Pets are considered overweight when body
weight exceeds ideal body weight by 10% to 20%, and pets
are considered obese when body weight exceeds ideal
body weight by 20% to 30% [4]. Worldwide, approximately
25% to 35% of adult cats and 35% to 40% of adult dogs are
overweight or obese [5,6]. Middle-aged neutered male cats
and middle-aged spayed female dogs are at the highest
risk for obesity [7]. According to Lund et al. [8], some
purebred dogs including Shetland Sheepdogs, Golden
Retrievers, Dachsunds, Cocker Spaniels, and Rottweilers* Correspondence: songkh@cnu.ac.kr
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unless otherwise stated.have a higher risk of obesity than other breeds. Canine
obesity is associated with several health conditions such as
insulin resistance, pancreatitis, cruciate ligament rupture,
lower urinary tract disease, oral disease, neoplasia, osteo-
arthritis and decreased longevity [9,10]. Additionally,
obesity could be risk factors for brachycephalic syndrome
and musculoskeletal problems and it may increase risks
associated with anesthesia [7]. Leptin was the first identi-
fied adipokine and has a role of regulating body fat mass
through appetite control and increased energy metabolism
[11]. Restriction of food intake results in a suppression of
leptin levels, which is returned by refeeding [11]. Circulat-
ing leptin levels correlates positively with adipose tissue
mass and exogenous leptin replacement decreases fast-
induced hyperphagia [11]. Circulating leptin interacts with
peripheral 5HT and decreases appetite [3]. The majority
of obese animals and humans have high serum leptin
levels, which suggests leptin resistance [11]. Leptin resist-
ance results from a signaling defect in leptin-responsive. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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brain [11]. Obesity can be a cause of leptin resistance,
but a lack of sensitivity to circulating leptin may also
induce obesity [11,12]. Adiponectin is believed to be
produced by mature adipocytes and it contributes to
increased insulin sensitivity, decreased blood glucose,
and decreased tissue triglyceride (TG) content in the
liver and muscle [12]. Related to obesity, adiponectin has
a negative correlation with obesity [12]. The decreasing of
adiponectin in obesity is more severe with visceral than
subcutaneous adiposity in human and the composition
of adiponectin is also changed. Increased production of
pro-inflammatory cytokines such as TNF-α and IL-6
with increased fat mass may inhibit adiponectin gene
expression [12]. Serotonin (5-hydroytryptamine or 5HT)
is associated with numerous behavioral and psychological
factors and is a biochemical marker of mood [13,14].
5HT is involved in the hypothalamic regulation of energy
consumption and 5HT levels in the central nervous
system (CNS) are influenced by energy conditions [15].
In the CNS, 5HT has a hypophagic effect owing to an
inhibitory interaction with the orexigenic system through
hypocretins and neuropeptide Y (NPY). 5HT also likely
has a stimulatory effect on the anorexigenic melanocortin
system [16]. Concerning interactions among leptin and
5HT, a previous mouse model study reported that periph-
eral leptin levels were reduced by 5HT, and 5HT exerted a
direct effect on adipocytes and regulated leptin release
from adipocytes [15]. Few studies have been published
looking at the role of 5HT and the relationship between
peripheral circulating serotonin and obesity [14,15]. There
have been no studies performed to evaluate peripheral
5HT levels in obese dogs until now. The aim of this study
was to identify differences and correlations among per-
ipheral concentrations of leptin, adiponectin, and 5HT
between lean and naturally obese dogs.
Methods
Ethics statement
Blood samples of dogs owned by private individuals were
used in the present study. The sample collection protocol
was approved by Laboratory Animals of Chungnam
National University committee (approved No. CNU 00370)
and the investigators adhered to the Guide for the Care
and Use of Laboratory Animals of Chungnam National
University.
Animals and sampling
A total of 100 healthy dogs (age range: 1 to 15 years-old;
mean age: 7 years) owned by clients of Chungnam National
University Veterinary Medicine Teaching Hospital were
recruited to be in the study from March 2012 to February
2013. Before examination, informed client consent was
obtained and we adhered to a high standard of veterinarycare. Owners were asked to have their dogs fast for
12 hours prior to presentation for blood sampling. One
investigator weighed and examined each dog to screen
for potential underlying inflammatory conditions. The
same investigator determined a body condition score
(BCS) and assigned the dog to either the control group
(BCS 4-5/9) or the obese group (BCS 7.5-9/9) utilizing
a 9-point BCS system [17]. A screening test for overall
health included a physical examination, along with history
taking, complete blood count (CBC), serum biochemistry,
electrolyte analysis, total thyroxine (tT4), and adreno-
corticotropic hormone (ACTH) assay. After the screening
test, 18 dogs were excluded in this study due to under-
lying disease including liver failure, heart disease and
hyperadrenocorticism. Also, dogs that were receiving sero-
tonergic drugs, such as fluoxetine or being fed serotonin-
containing food, such as bananas, tomatoes, pineapples,
or walnuts were excluded from this study. Finally, 82
healthy dogs were enrolled for this research (Table 1).
Sample analysis
For adipokine analyses, we collected blood by venipunc-
ture using minimal restraint from the jugular vein of dogs
that were deemed healthy based on history and physical
examination. A fraction of the collected blood was placed
in an EDTA tube for a CBC. The remaining blood was
allowed to clot at room temperature for 30 minutes and
then centrifuged at 2,500 rpm for 15 minutes. Serum and
plasma samples were frozen and stored at −80°C, and
until analysis of adipokines, 5HT, tT4, cortisol, TG and
cholesterol levels.
Sandwich enzyme-linked immunosorbent assay and
hormone assay
Serum leptin and adiponectin levels were measured
according to the manufacturer’s protocol using a canine
leptin commercial sandwich enzyme-linked immuno-
sorbent assay (ELISA) kit (Millipore, Billerica, MA, USA)
and canine adiponectin commercial ELISA kit (Milipore,
Billerica, MA, USA). All samples were tested in duplicate.
Serum tT4 and cortisol levels were quantified using an
Immulite 1000 immunoassay analyzer (Siemens Medical
Diagnostics, Los Angeles, CA, USA). Plasma 5HT concen-
trations were measured by a commercially available ELISA
kit (Serotonin EIA Kit, Enzo Life Sciences Inc, MI, USA)
according to the manufacturer’s instructions [18].
Statistical analysis
Statistical analyses were performed by a commercially
available computer-based software program (IBM SPSS
Statistics 20.0.0, SPSS Inc., Chicago, IL USA). Age, body
weight, and BCS results are presented as means with a
standard error. Serum leptin, adiponectin, 5HT, TG,
cholesterol, tT4, and cortisol levels are presented as
Table 1 Profile of dogs in lean and obese groups (Mean ± SE)
Age Body weight BCS Gender Breed
Lean group 4.12 ± 2.77 5.47 ± 0.23 4.32 ± 0.07 Male (4) Shih-Tzu (5)
Male Poodle (3)
Castrated (9) Maltese (3)
Female (13) Mongrel (12)




Obese group 7.07 ± 3.20 10.73 ± 1.25 8.09 ± 0.09 Male (1) French bulldog (1)
Male Shih-Tzu (13)
Castrated (18) Cocker spaniel (5)
Female (10) Poodle (3)
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A P value of < 0.05 was considered significant. Age, BCS,
leptin, adiponectin, 5HT, total thyroxine (tT4), cortisol,
platelets, TG and cholesterol were compared between the
lean group and the obese group using the independent
t-test. The correlation between variables including age,
sex, platelets, leptin, adiponectin, 5HT, TG, cholesterol,
tT4, cortisol, and BCS were assessed by Pearson’s cor-
relation coefficients.
Results
Leptin, adiponectin and 5HT levels in the lean and
obese groups
In this study, dogs were separated by BCS into lean and
obese groups. Each group had 41 dogs. In the lean group
(male, n = 13; female, n = 28), the average age was
4.12 years, the average body weight was 5.47 kg, and the
average BCS was 4.32. In the obese group (male, n = 19;
female, n = 22), the average age was 7.07 years, the aver-
age body weight was 10.73 kg, and the average BCS was
8.09. The distributions of BCS and gender in each group
are presented in Table 1. Obesity-related parameters,
including leptin, adiponectin and 5HT levels, are pre-
sented in Table 2. The obese group showed significantly
higher body weights and BCS (both p < 0.01). Leptin, TG,
and cholesterol levels were higher in the obese group
than in the lean group (p < 0.01). Adiponectin and 5HTlevels were higher in the lean group than the obese
group (p < 0.01). The distribution of plasma 5HT concen-
tration is shown in Figure 1. No significant differences
were found in tT4 or cortisol between the lean and obese
groups. To evaluate the effect of sex or being castrated/
spayed, we divided animals intact and castrated or spayed
within the lean and obese groups. In the obese group,
spayed females had a lower level of 5HT than the intact
female group (Table 3). The general tendency of the obes-
ity related parameter was not influenced by gender status
(Table 3). To estimate the effect of aging on obesity
related parameters, the dogs were divided into two groups
(young: < 8 years old; old: > 8 years old) and within each
group, we created two subgroups (lean vs. obese group).
Regardless of age, the lean group showed a lower level of
BCS and leptin, and a higher level of 5HT than the obese
group (Table 4).
Correlation between variables
Leptin (r = 0.628, p < 0.01), TG (r = 0.491, p < 0.01) and
cholesterol (r = 0.419, p < 0.01) levels were positively
correlated with BCS and adiponectin (r = −0.446, p < 0.01)
and 5HT (r = −0.490; p < 0.01) levels were negatively
correlated with BCS (Figure 2). Leptin was negatively
correlated with adiponectin (r = −0.294; p < 0.01) and
5HT (r = −0.343; p < 0.01), but leptin was positively corre-
lated with cholesterol (r = 0.516; p < 0.01) (Figure 3).
Table 2 Obesity parameter, adipokines (leptin and adiponectin) and serotonin levels between lean and obese groups
(Mean ± SE, 95% confidence interval)
Lean group Obese group P-value
(N = 41) (N = 41)
Mean ± SE 95% CI Mean ± SE 95% CI
BCS 4.31 ± 0.07 4.16 4.45 8.07 ± 0.09 7.89 8.25 < 0.01
Leptin (ng/mL) 2.69 ± 1.08 1.91 3.46 10.27 ± 1.20 7.91 12.63 < 0.01
Adiponeptin (μg/mL) 12.18 ± 1.09 10.05 14.31 6.23 ± 0.79 4.66 7.78 < 0.01
Serotonin (ng/mL) 792.96 ± 102.45 749.49 839.47 560.43 ± 245.95 491.28 623.19 < 0.01
Triglyceride (mg/dL) 51.53 ± 29.03 41.78 61.28 138.64 ± 125.46 92.13 180.95 < 0.01
Cholesterol (mg/dL) 211.03 ± 73.80 186.23 235.82 289.97 ± 112.93 254.86 325.88 0.01
Total T4 (μg/dL) 1.74 ± 0.66 1.50 1.97 1.55 ± 0.55 1.36 1.726 0.19
Cortisol (μg/dL) 4.61 ± 2.36 3.78 5.44 5.39 ± 3.43 4.26 6.52 0.29
CI; confidence interval.
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In the current research, we found that obese dogs had
lower 5HT and adiponectin levels and higher leptin levels
than lean dogs. TG and cholesterol levels were high in the
obese group compared with the lean group. Body fat is no
longer considered simply as energy storage. Adipocytes
produce many cytokines and hormones referred to as
fat-derived peptides [12]. Adipokines include adiponectin,
leptin, resistin, amyloid A, transforming growth factor
β, tumor necrosis factor and interleukin-6 [7,12,19].
Currently, there is much interest in the role of adipokinesFigure 1 Serotonin concentration between lean and obese
groups. Data are presented as boxes and whiskers. Each box includes
the interquartile range, whereas the line within a box represents the
median, and the whiskers represent the range, extending to a maximum
of 1.5 times the interquartile range. Serotonin levels were significantly
lower in obese group compared with that of lean group. **p < 0.01:
significant difference were observed between lean and obese groups.in canine obesity [19]. Circulating leptin levels are posi-
tively correlated with adipose tissue mass, and exogenous
leptin replacement decreases fast-induced hyperphagia
[11]. However, the majority of obese animals and humans
have high serum leptin levels, which suggests leptin resist-
ance [11]. In this study, the serum leptin levels of dogs in
the obese group were higher than those in the lean group,
and adiponectin levels in the obese group were lower than
those in the lean group (Table 2). Obesity can be a cause
of leptin resistance, but a lack of sensitivity to circulating
leptin may also induce obesity [11,20].
Middle-aged neutered male cats and middle-aged spayed
female dogs have a high risk of being overweight or obese
[8,21]. With aging, lean body mass gradually declines,
resulting in a reduced basal metabolic rate (BMR) and
reduced total daily energy needs. If accompanied by
reduced exercise, the loss of lean body mass will be
exacerbated. This study revealed no significant differ-
ences in obesity-related parameters, with the exception
of cholesterol, between young and old dogs. However,
spayed female dogs had a significantly higher BCS than
intact females and this is the same result as a previous
study [8]. Neutering decreases the BMR by 25% to 33%
[22]. Most dog owners are unaware of the altered
metabolic activity after ovariohysterectomy and do not
decrease the food supply, which leads to increased food
intake in dogs. This feeding behavior is often accompanied
by decreased physical activity and, consequently, spayed
female dogs gain weight easily.
In our study, the obese group had higher TG and chol-
esterol levels than the lean group. However, in the obese
group, the average TG level (138.64) did not exceed
1000 mg/dL and the average cholesterol level (289.97)
was less than 750 mg/dL. The goal of hyperlipidemia
treatment is to maintain plasma lipid concentrations
under a level at which health problems are likely to
occur. Dietary intervention is recommended in dogs that
Table 3 Obesity parameter, adipokines, and serotonin levels according to sex (Mean ± SE)
Males Females
Intact Castrated Intact Spayed
(N = 4) (N = 9) (N = 13) (N = 15)
Lean group BCS 4.25 ± 0.25 4.44 ± 0.17 4.0 ± 0 4.53 ± 0.13
Leptin (ng/mL) 5.06 ± 2.85 2.60 ± 0.48 1.59 ± 0.18 2.88 ± 0.68
Adiponectin (μg/mL) 10.53 ± 1.29 11.55 ± 2.20 14.31 ± 2.61 11.14 ± 1.42
Serotonin (ng/mL) 871.31 ± 61.31 736.0 ± 43.98 739.49 ± 15.69 832.21 ± 22.45
Triglyceride (mg/dL) 64.75 ± 18.32 42.0 ± 9.54 38.57 ± 7.08 51.21 ± 5.44
Cholesterol (mg/dL) 282.0 ± 38.02 218.33 ± 27.36 163.14 ± 18.02 204.57 ± 17.45
Intact Castrated Intact Spayed
(N = 1) (N = 18) (N = 10) (N = 12)
Obese group BCS 8 8.16 ± 0.14★★ 8.10 ± 0.23★★ 7.67 ± 0.22★★
Leptin (ng/mL) 11.6 11.66 ± 1.70★★ 9.91 ± 3.20★★ 8.39 ± 1.91★★
Adiponectin (μg/mL) 5.2 5.92 ± 1.07★ 6.80 ± 1.38★★ 6.29 ± 1.99★
Serotonin (ng/mL) 622.45 533.26 ± 58.89★★ 682.14 ± 59.95 478.0 ± 74.06*,★★
Triglyceride (mg/dL) 288 154.16 ± 35.13★ 148.57 ± 45.48★ 95.91 ± 14.08★
Cholesterol (mg/dL) 325 301.38 ± 23.22★ 240.20 ± 24.14★ 296.72 ± 49.91★
*p < 0.05 between intact and spayed groups.
★p <0.05 between lean and obese groups.
★★p <0.01 between lean and obese groups.
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terol levels over 750 mg/dL [23]. In the present study,
the obese group had high TG and cholesterol levels, but
the likelihood of health problems induced by hyperlipid-
emia in these animals is marginal. In this study, the per-
ipheral 5HT levels in the obese group were significantly
lower than in the lean group, which is similar to human
study results [13]. Furthermore, a negative correlation
between leptin and 5HT was observed in this study. In
the obese group, spayed female showed lower 5HT levels
compared with intact female. In human studies, natural
postmenopausal and ovariectomised women had lower
5HT levels than regularly menstruating women [24].
Estrogen withdrawal alters serotonergic functioning and
exogenous estrogen supplementation could increase 5HTTable 4 Obesity parameter, adipokines and serotonin levels a
Young group (< 8-year old) (N = 58)
Lean group Obese group
(N = 36) (N = 22)
BCS 4.31 ± 0.08 8.09 ± 0.15
Leptin (ng/mL) 2.64 ± 0.44 10.29 ± 1.87
Adiponeptin (μg/mL) 12.28 ± 1.19 5.83 ± 0.90
Serotonin (ng/mL) 794.70 ± 16.76 587.71 ± 54.94
Triglyceride (mg/dL) 48.21 ± 4.41 150.56 ± 34.27
Cholesterol (mg/dL) 205.97 ± 14.34 276.65 ± 19.72
Total T4 (μg/dL) 1.82 ± 0.12 1.50 ± 0.13
Cortisol (μg/dL) 4.42 ± 0.42 4.80 ± 0.83levels in postmenopausal women [15,24]. As with human
studies, we found a similar phenomenon in spayed obese
dogs. 5HT throughout the body influences food consump-
tion by controlling satiety [25]. Therefore, low levels of
5HT could be a risk factor for obesity due to increased
appetite. 5HT has a hypophagic effect in the CNS, and
5HT concentrations in the peripheral nervous system
may not necessarily equate to 5HT levels or availability
in the brain, since 5HT cannot cross the blood–brain
barrier [14]. L-tryptophan, an amino acid and precursor to
serotonin is converted to 5-hydroxy-L-tryptophan (5-HTP)
and then to serotonin in both the CNS and PNS [26]. Brain
tryptophan and serotonin levels are determined by the
ratio of plasma tryptophan to other large neutral amino
acids (LNAAs), which compete with tryptophan for uptakeccording to age (Mean ± SE)
Old group (> 8-year old) (N = 24)
P- value Lean group Obese group P- value
(N = 5) (N = 19)
< 0.01 4.40 ± 0.24 7.89 ± 0.16 < 0.01
< 0.01 3.02 ± 0.66 10.24 ± 1.47 0.023
< 0.01 11.47 ± 2.66 6.68 ± 1.39 0.13
< 0.01 780.41 ± 57.01 528.83 ± 53.80 0.032
< 0.01 70.80 ± 22.19 131.66 ± 26.08 0.251
< 0.01 240.40 ± 19.50 299.68 ± 31.85 0.363
0.103 1.38 ± 0.17 1.58 ± 0.13 0.434
0.652 5.54 ± 1.17 5.97 ± 0.78 0.793
Figure 2 Correlation between BCS and obesity parameters. (A) BCS and adiponectin showed negative correlation (r = −0.446, p < 0.01).
(B) BCS and Cholesterol showed positive correlation (r = 0.419, p < 0.01). (C) BCS and leptin showed positive correlation (r = 0.628, p < 0.01).
(D) BCS and serotonin showed negative correlation (r = −0.490, p < 0.01). (E) BCS and tirglyceride showed positive correlation (r = 0.491, p < 0.01).
Figure 3 Correlation among leptin, adiponectin, cholesterol and serotonin. (A) Leptin and adiponectin showed negative correlation (r = −0.294,
p < 0.01). (B) Leptin and Cholesterol showed positive correlation (r = 0.516, p < 0.01). (C) Leptin and serotonin showed negative correlation (r = −0.343,
p < 0.01).
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released, which promotes uptake of the LNAAs, but not
tryptophan, into skeletal muscles. This helps tryptophan
pass more easily into the brain, which increases serotonin
production in the brain [14,25]. Increased 5HT produc-
tion in the brain from carbohydrate-rich diets can induce
mood-enhancing post-ingestion effects that motivate
intake of such foods and, consequently, promote weight
gain [14]. Circulating leptin interacts with peripheral
5HT and decreases appetite [3]. One mouse model study
reported that plasma leptin was reduced by 5HT, and
5HT exerted a direct effect on adipocytes and regulated
leptin release from adipocytes [15]. Moreover, 5HT is able
to down-regulate adiponectin in the mouse adipocyte
cell line [27]. Peripheral 5HT concentration of the obese
group is significantly lower than the lean group in this
study, and this is similar with human study results.
Enterochromaffin (EC) cells in the intestinal epithelium
release 5HT according to mechanical stimulation, to
promote transit [28]. Experimentally a diet-induced obesity
model showed decreased 5HT levels with a decreased
number of EC cells [11]. The inflammation associated
with changes in the GI microbiota is considered as the
reason for decreased 5HT availability in obese status
[28,29]. 5HT, as a neurotransmitter, controls food satiety,
and, therefore, high 5HT concentrations decrease leptin
and adiponectin concentrations. We found that 5HT is
negatively correlated to leptin. Based on the previous
result of a mouse model that 5HT could reduce the
secretion of leptin, we can consider the possibility that
lowered 5HT failed to properly suppress increasing
secretion of leptin [15]. As seen in Figure 3C, however,
there are more dogs presenting a high level of 5HT at a
low level of leptin than ones presenting a low level of
5HT at a high level of leptin. Therefore, further studies
would be needed with a larger number of dogs to evaluate
the interaction between 5HT and leptin. The low level of
adiponectin in the obese group was similar to the results
of previous studies [30,31]. Adiponectin was negatively
correlated with obesity [32]. The decreased adiponectin
level in obesity is more significant in visceral than sub-
cutaneous adiposity in humans, and the composition of
adiponectin also changes with location in the body. 5HT
suppresses adiponectin, and, therefore, a high peripheral
adiponectin level can induce a low 5HT level. However,
we observed low levels of both 5HT and adiponectin in
the obese group in our study.
Through this research, we found that the level of
peripheral 5HT is low in the obese group. Since 5HT
is related to intestinal mobility, we can expect that a
lower level of 5HT could reduce intestinal mobility. The
reduced mobility, in turn, could allow gut microorganism
to undergo energy harvesting for a longer period, which
consequentially could aggravate obesity. Based on thishypothesis, further research is needed to identify that 5HT
treatment could actually activate intestinal mobility and
how it might work to reduce obesity. It is possible that
humans are becoming obese as a result of overeating in
order to maintain serotonin levels and the resulting positive
mood. Therefore, serotonin agonists may be a treatment
option for obesity in humans [33]. From this research, we
found that the 5HT level of obese dogs was lower than that
of lean dogs, therefore, we could assume that a serotonin
agonist might be helpful in increasing the 5HT level in
obese dogs. Increased 5HT levels via a serotonin agonist
may control appetite and prompt intestinal motility. In
human medicine, high levels of 5HT may be dangerous,
and is known as serotonin syndrome [34]. Unfortunately,
there have been few studies on the relationship between
obesity and 5HT in the veterinary field so far. As obesity
is considered to cause several diseases, based on the
results of our research, more studies are needed to
determine the impact and the mechanism of 5HT on
leptin and adiponectin. Furthermore, as a treatment
option for obesity in veterinary medicine, clinical trials
of a 5HT agonist and considerations of adverse effects
should be pursued.
There are a few limitations to this study. First of all,
concerning the selection of the dogs in this study, the
distribution of dogs does not balance between intact and
castrated males. For example, there was a relatively fewer
number of intact males than castrated males in the obese
group. In addition, even though we identified several
corrections among adipokines, 5HT, and other obesity-
related parameters, we did not go further to formulate
the mechanism of interactions among them. Although
we found a significant difference in 5HT levels between
the lean and obese groups, there was also variation
within the groups. We tried to control for factors that
influence 5HT levels such as platelet, diarrhea and
food. However, we could not control emotion, social
situation or the rhythm activity of an enrolled subject.
Conclusions
5HT is an important appetite control neurotransmitter,
but there are limited studies regarding 5HT levels related
to obesity in veterinary medicine. Overall, we found that
peripheral 5HT levels were lower in obese dogs than lean
dogs, and 5HT was negatively correlated with BCS and
leptin levels. To the best of our knowledge, this is the first
study to evaluate peripheral 5HT levels in obese dogs.
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